SUNPHARMA Share Price Performance
₹1,941.10
242.10 (14.25%)
4.8% undervalued intrinsic discount
₹2,039.91
Fair Value
Price ₹1,941.10
AnalystConsensusTarget ₹2,039.91
Fair Value₹2,039.91
Share Pricen/a
Analysis Article • Jul 09
Sun Pharmaceutical Industries Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 34 Fair Values set on narratives written by author
SUNPHARMA Community Narratives
AN
Fair Value
·Fair Value ₹2.04k 4.8% undervalued intrinsic discount
Specialty Therapies And Emerging Markets Will Unlock Future Potential
0users have liked this narrative
0users have commented on this narrative
18users have followed this narrative
Specialty Therapies And Emerging Markets Will Unlock Future Potential
Sun Pharma is trying to move beyond plain low-cost medicines by pushing more specialised treatments and growing faster in newer overseas markets. That shift could lift its growth and profits, but only if it clears regulatory hurdles and its new launches win out against tough competition and pricing pressure.Read more
AN
₹2.04k
4.8% undervalued intrinsic discount
Fair Value
Revenue
10.95% p.a.
Profit Margin
22.77%
Future PE
38.53x
Price in 2029
₹2.9k
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
SUNPHARMA: Obesity And Diabetes Franchise Will Drive Future Stock Upside
Fair Value: ₹2.04k 4.8% undervalued intrinsic discount
18 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Sun Pharmaceutical Industries Limited Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 31, 2026
- 47.84
- 78.66%
- 19.64%
- 4.9%
About SUNPHARMA
- Founded
- 1983
- Employees
- 47000
- CEO
- WebsiteView website
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; specialty medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers generics and APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.